Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.
Product Name: 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate
CAS Number: 376608-65-0
Molecular Weight:  367.3522
Molecular Formula:  C14H25NO10
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.